| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | Roscovitine | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.4 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.026 | 0.4 |
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.15 | 0.4 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |